A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score.
Zheng X, Lu T, Wu S, Lin X, Bai J, Chen X, Miao Q, Yan J, Jiang K, Zhang L, Zheng X, Wang H, Xu Y, Xiao W, Li C, Peng W, Ding J, Zhong Q, Zou Z, Yang S, Li Y, Chen S, Zhang Q, Yan J, Tang G, Cai Y, Kang M, Mok TSK, Lin G.
Zheng X, et al. Among authors: mok tsk.
MedComm (2020). 2024 Mar 9;5(3):e493. doi: 10.1002/mco2.493. eCollection 2024 Mar.
MedComm (2020). 2024.
PMID: 38463396
Free PMC article.